Search results
CAR T-Cell therapy revolutionised landscape of cancer treatment: Doctors
Investing.com· 3 days agoNew Delhi, May 21 (IANS) A 42-year-old man from Bengaluru has successfully achieved "durable...
Cell therapy: Do the benefits outweigh the risks?
WILX 10 Lansing· 2 days agoLocke, MD, Dir., Immune Cell Therapy Program at Moffitt Cancer Center says, “Immunotherapy has really come on as quite an advance in ...
AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
Pharmaceutical Technology via Yahoo Finance· 3 days agoXcell...and chief scientific officer James Lim stated: “Current cell therapies have been highly...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
WJTV Jackson· 12 hours agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions and present their latest discoveries from their innovative cancer ...
Keeping CAR T Cells Sharp
The Scientist· 3 days agoResearchers have observed that certain types of CAR T cells are more effective at eradicating cancer. One especially advantageous quality is a...
Anixa advances CAR-T trial for ovarian cancer with fifth patient By Investing.com
Investing.com· 3 days agoAnixa Biosciences, Inc. (NASDAQ: NASDAQ:ANIX), a clinical-stage biotechnology company, has begun...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
NBC San Diego· 23 hours agoTargeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation...
New Vaccine “Booster” Found To Promote Powerful Anti-Tumor Immunity
SciTechDaily· 12 hours agoResearchers at Trinity College Dublin have achieved a significant breakthrough that could lead to...
New thesis explores cancer treatment that can prevent relapse
Medical Xpress· 4 days agoRelapse following initial treatment efficacy remains a major clinical challenge for many cancers....
Achilles Therapeutics and Arcturus team up for cancer vaccine By Investing.com
Investing.com· 2 days agoAchilles Therapeutics plc (NASDAQ: ACHL), a biopharmaceutical company specializing in T cell...